Journal Home Online First Current Issue Archive For Authors Journal Information 中文版

Strategic Study of CAE >> 2014, Volume 16, Issue 10

Exploration of Strategies for Chronic Disease Prevention and Control and Relevant System Construction in China #$NL#$NLWang Longde #$NL#$NLAbstract

Chinese Preventive Medicine Association,Beijing 100021,China

Received: 2014-08-05 Available online: 2014-10-30 09:05:03.000

Next Previous

Abstract

Chronic non-communicable diseases have become a major threat to humanity. International studies have shown that of 57 million deaths worldwide in 2008,63 %(36 million) were caused by chronic non- communicable diseases of which 80 %(29 million)occurred in low and middle income countries. The WHO predicts that if the current situation continues to develop,the annual number of deaths due to chronic non-communicable diseases will increase to 55 million in 2030. As acceleration of industrialization,urbanization and population aging processes and rapid changes of national lifestyle,the morbidity and mortality rates of chronic diseases are showing a rapid growth trend in China. Therefore,dealing with the prevalence of chronic non-communicable diseases is becoming one of the current major issues that must be considered as soon as possible in China. On the basis of summarizing the status of major chronic diseases in China,analyzing the key issues and key factors in chronic disease prevention and control and studying and summarizing the experience from the previous projects,this paper proposes the following recommendations for the strategies for chronic disease prevention and control and relevant system construction that China should adopt and develop:All relevant government departments should formulate corresponding policies;establish a coordinated and efficient work system with rational structure and clear division of tasks and responsibilities within the system;implement the development of“integrated medicine”in system,work norms and requirements and thereby improve the performance and efficiency in chronic disease prevention and control in China. 

Figures

图1

图2

References

[ 1 ] 第六十六届世界卫生大会. 预防和控制非传染性疾病问题联合 国大会高级别会议的政治宣言的后续行动(WHA66.10)[R]. 日 内瓦:世界卫生大会,2013.

[ 2 ] 世界卫生组织. 2013年世界卫生报告:全民健康覆盖研究[R]. 日内瓦:世界卫生组织,2013.

[ 3 ] 陈 竺. 全国第三次死因回顾抽样调查报告[M]. 北京:中国协 和医科大学出版社,2008.

[ 4 ] 世界银行. 创建健康和谐生活:遏制中国慢性病流行[R]. 2011.

[ 5 ] 中华人民共和国国务院新闻办公室《. 中国的医疗卫生事业》白 皮书[R]. 2012.

[ 6 ] 中国疾病预防控制中心慢性非传染性疾病预防控制中心.2012 年全国死因监测报告[R]. 2014.

[ 7 ] 中国残疾人联合会. 2006年“第二次全国残疾人抽样调查主要 数据公报及其问答”[EB/OL](http://temp07.cdpj.cn/gzh/2007- 01/25/content_7647.htm).

[ 8 ] 卫生部卫生发展研究中心. 2012中国卫生总费用研究报告[R]. 2012.

[ 9 ] 世界卫生组织. 预防慢性病:一项至关重要的投资[R]. 2005.

[10] “健康中国2020”战略研究报告[M]. 北京:人民卫生出版社, 2012:254.

[11] 国家卫生计生委. 2013年我国卫生和计划生育事业发展统计 公报[R]. 2014.

[12] Chobanian A V. Improved hypertension control: cause for some celebration [J]. JAMA,2010,303(20):2082-2083. link1

[13] Wei J W,Wang J G,Huang Y,et al. Secondary prevention of ischemic stroke in urban China [J]. Stroke,2010,41(5):967- 974. link1

[14] Schwamm L H,Ali S F,Reeves M J,et al. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines- stroke hospitals [J]. Circ Cardiovasic Qual Outcomes, 2013,6(5):543-549. link1

[15] Bauer A,Limburg M,Visser M C. Variation in clinical practice of intravenous thrombolysis in stroke in the Netherlands [J]. Cereborvasc Dis Extra,2013,3(1):74-77. link1

[16] Wang Y,Liao X,Zhao X,et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China:Aanalysis of the results from the Chinese National Stroke Registry (CNSR)[J]. Stroke,2011,42(6):1658-1664. link1

Related Research